325 related articles for article (PubMed ID: 10548201)
1. Discrimination of infectious and noninfectious causes of early acute respiratory distress syndrome by procalcitonin.
Brunkhorst FM; Eberhard OK; Brunkhorst R
Crit Care Med; 1999 Oct; 27(10):2172-6. PubMed ID: 10548201
[TBL] [Abstract][Full Text] [Related]
2. The role of procalcitonin and IL-6 in discriminating between septic and non-septic causes of ALI/ARDS: a prospective observational study.
Tsantes A; Tsangaris I; Kopterides P; Kapsimali V; Antonakos G; Zerva A; Kalamara E; Bonovas S; Tsaknis G; Vrigou E; Maniatis N; Dima K; Armaganidis A
Clin Chem Lab Med; 2013 Jul; 51(7):1535-42. PubMed ID: 23314554
[TBL] [Abstract][Full Text] [Related]
3. Comparison of procalcitonin and C-reactive protein as markers of sepsis.
Luzzani A; Polati E; Dorizzi R; Rungatscher A; Pavan R; Merlini A
Crit Care Med; 2003 Jun; 31(6):1737-41. PubMed ID: 12794413
[TBL] [Abstract][Full Text] [Related]
4. Discrimination of sepsis and systemic inflammatory response syndrome by determination of circulating plasma concentrations of procalcitonin, protein complement 3a, and interleukin-6.
Selberg O; Hecker H; Martin M; Klos A; Bautsch W; Köhl J
Crit Care Med; 2000 Aug; 28(8):2793-8. PubMed ID: 10966252
[TBL] [Abstract][Full Text] [Related]
5. Alveolar neopterin, procalcitonin, and IL-6 in relation to serum levels and severity of lung injury in ARDS.
Lederer W; Stichlberger M; Hausdorfer J; Fuchs D; Mutz NJ; Wiedermann FJ
Clin Chem Lab Med; 2013 Sep; 51(9):e213-5. PubMed ID: 23612545
[No Abstract] [Full Text] [Related]
6. Plasma procalcitonin and C-reactive protein in acute septic shock: clinical and biological correlates.
Claeys R; Vinken S; Spapen H; ver Elst K; Decochez K; Huyghens L; Gorus FK
Crit Care Med; 2002 Apr; 30(4):757-62. PubMed ID: 11940741
[TBL] [Abstract][Full Text] [Related]
7. [Value of procalcitonin on predicting the severity and prognosis in patients with early ARDS: a prospective observation study].
Yu Z; Ji M; Hu X; Yan J; Jin Z
Zhonghua Wei Zhong Bing Ji Jiu Yi Xue; 2017 Jan; 29(1):34-38. PubMed ID: 28459401
[TBL] [Abstract][Full Text] [Related]
8. Procalcitonin release patterns in a baboon model of trauma and sepsis: relationship to cytokines and neopterin.
Redl H; Schlag G; Tögel E; Assicot M; Bohuon C
Crit Care Med; 2000 Nov; 28(11):3659-63. PubMed ID: 11098970
[TBL] [Abstract][Full Text] [Related]
9. [Role of procalcitonin in the differentiation and surveillance of systemic inflammatory response syndrome].
Liu XL; Du B; Pan JQ; Xu Y; Hua BL
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2005 Feb; 27(1):48-52. PubMed ID: 15782493
[TBL] [Abstract][Full Text] [Related]
10. Use of a Combination Biomarker Algorithm To Identify Medical Intensive Care Unit Patients with Suspected Sepsis at Very Low Likelihood of Bacterial Infection.
Han JH; Nachamkin I; Coffin SE; Gerber JS; Fuchs B; Garrigan C; Han X; Bilker WB; Wise J; Tolomeo P; Lautenbach E;
Antimicrob Agents Chemother; 2015 Oct; 59(10):6494-500. PubMed ID: 26239984
[TBL] [Abstract][Full Text] [Related]
11. Procalcitonin as a prognostic and diagnostic tool for septic complications after major trauma.
Castelli GP; Pognani C; Cita M; Paladini R
Crit Care Med; 2009 Jun; 37(6):1845-9. PubMed ID: 19384224
[TBL] [Abstract][Full Text] [Related]
12. Procalcitonin (PCT) is useful in predicting the bacterial origin of an acute circulatory failure in critically ill patients.
Cheval C; Timsit JF; Garrouste-Orgeas M; Assicot M; De Jonghe B; Misset B; Bohuon C; Carlet J
Intensive Care Med; 2000 Mar; 26 Suppl 2():S153-8. PubMed ID: 18470711
[TBL] [Abstract][Full Text] [Related]
13. The clinical usefulness of procalcitonin measurement for assessing the severity of bacterial infection in critically ill patients requiring corticosteroid therapy.
Kushimoto S; Shibata Y; Koido Y; Kawai M; Yokota H; Yamamoto Y
J Nippon Med Sch; 2007 Jun; 74(3):236-40. PubMed ID: 17625373
[TBL] [Abstract][Full Text] [Related]
14. Diagnostic and prognostic value of procalcitonin in patients with septic shock.
Clec'h C; Ferriere F; Karoubi P; Fosse JP; Cupa M; Hoang P; Cohen Y
Crit Care Med; 2004 May; 32(5):1166-9. PubMed ID: 15190968
[TBL] [Abstract][Full Text] [Related]
15. Role of procalcitonin, C-reactive protein, interleukin-6, interleukin-8 and tumor necrosis factor-alpha in the diagnosis of neonatal sepsis.
Kocabaş E; Sarikçioğlu A; Aksaray N; Seydaoğlu G; Seyhun Y; Yaman A
Turk J Pediatr; 2007; 49(1):7-20. PubMed ID: 17479639
[TBL] [Abstract][Full Text] [Related]
16. Procalcitonin as a marker of severity in septic shock.
Schröder J; Staubach KH; Zabel P; Stüber F; Kremer B
Langenbecks Arch Surg; 1999 Feb; 384(1):33-8. PubMed ID: 10367627
[TBL] [Abstract][Full Text] [Related]
17. Serial inflammatory biomarkers of the severity, course and outcome of late onset acute respiratory distress syndrome in critically ill patients with or at risk for the syndrome after new-onset fever.
Hoeboer SH; Groeneveld AB; van der Heijden M; Oudemans-van Straaten HM
Biomark Med; 2015; 9(6):605-16. PubMed ID: 26079964
[TBL] [Abstract][Full Text] [Related]
18. Procalcitonin: a marker of bacteraemia in SIRS.
Bell K; Wattie M; Byth K; Silvestrini R; Clark P; Stachowski E; Benson EM
Anaesth Intensive Care; 2003 Dec; 31(6):629-36. PubMed ID: 14719423
[TBL] [Abstract][Full Text] [Related]
19. Effect of sepsis and cardiac surgery with cardiopulmonary bypass on plasma level of nitric oxide metabolites, neopterin, and procalcitonin: correlation with mortality and postoperative complications.
Adamik B; Kübler-Kielb J; Golebiowska B; Gamian A; Kübler A
Intensive Care Med; 2000 Sep; 26(9):1259-67. PubMed ID: 11089751
[TBL] [Abstract][Full Text] [Related]
20. Sensitivity and specificity of various markers of inflammation for the prediction of tumor necrosis factor-alpha and interleukin-6 in patients with sepsis.
Oberhoffer M; Karzai W; Meier-Hellmann A; Bögel D; Fassbinder J; Reinhart K
Crit Care Med; 1999 Sep; 27(9):1814-8. PubMed ID: 10507603
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
